In line with these findings, Platek et al. [29] using multivariate logistic regression analysis showed that patients with elevated visfatin levels were almost 3-time more likely to experience RAF and recommended the use of visfatin as a marker for risk stratification in AF patients undergoing CA. Here, NAMPT is linked to atrial fibrillation.